| Host: |
HEK293 cells |
| Reactivity: |
SARS-COV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike S1+S2 ECD (S-ECD)-C-hFc protein was developed from hek293 cells and has a target region of C-hFc. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Immobilized Human ACE2, His Tag at 5 Mu g/mL (100 Mu L/Well). Dose response curve for SARS-COV-2 Spike S, hFc Tag with the EC50 of 0.9 Mu g/mL determined by ELISA. |
| Immunogen Region: |
Val16-Glu1188 |
| Immunogen: |
Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Glu1188) of SARS-COV-2 Spike S fused with hFc tag at the C-terminal. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
